CDK46 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer a US Food and Drug Administration pooled analysis
本文档由 f061da46b0 分享于2020-05-13 15:36
CDK46 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer a US Food and Drug Administration pooled analysis
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~